Diabetes, Vol 36, Issue 8 925-931, Copyright © 1987 by American Diabetes Association

ARTICLES

Reversal of insulin resistance in diabetic rat adipocytes by insulin therapy. Restoration of pool of glucose transporters and enhancement of glucose-transport activity

E Karnieli, M Armoni, P Cohen, Y Kanter and R Rafaeloff

To determine the role of insulin in reversing the insulin resistance associated with depletion of the intracellular pool of glucose transporters, streptozocin-induced diabetic rats were treated with 5 U/day s.c. of insulin for 0, 8, or 14 days. At each time point, adipose cells were isolated, and 3-O-methylglucose transport was measured in the absence and presence of 1000 microU/ml insulin. With the cytochalasin B-binding assay, concentrations of glucose transporters in the plasma and the low-density microsomal membrane fractions were determined. Eight-day insulin therapy enhanced glucose transport rate (mean +/- SE) from 0.2 +/- 0.0 to 1.1 +/- 0.1 fmol X cell-1 X min-1 in the basal state and from 0.8 +/- 0.1 to 5.5 +/- 0.4 fmol X cell-1 X min-1 in the insulin-stimulated state in untreated and treated diabetic rats, respectively; this is a 3-fold increment of glucose transport rate in both states compared with control rats. After 14-day insulin therapy, glucose-transport activity declined toward normal but still remained approximately 1.5- and 4-fold higher than control and diabetic rats, respectively. Despite the persistent enhancement of glucose transport rate, concentration of glucose transporters in the intracellular pool was restored only to its prediabetic state. Likewise, the increased concentration of glucose transporters in the plasma membranes after insulin stimulation was similar to that of control rats. Thus, we suggest that 8-14 days of insulin therapy reversed the insulin resistance in diabetic rat adipocytes by at least two mechanisms: restoration of the intracellular pool of glucose transporters and enhancement of glucose-transport activity.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Nedachi and M. Kanzaki Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E817 - E828. [Abstract] [Full Text] [PDF]

				M. Armoni, N. Kritz, C. Harel, F. Bar-Yoseph, H. Chen, M. J. Quon, and E. Karnieli Peroxisome Proliferator-activated Receptor-{gamma} Represses GLUT4 Promoter Activity in Primary Adipocytes, and Rosiglitazone Alleviates This Effect J. Biol. Chem., August 15, 2003; 278(33): 30614 - 30623. [Abstract] [Full Text] [PDF]

				M. Armoni, M. J. Quon, G. Maor, S. Avigad, D. N. Shapiro, C. Harel, D. Esposito, Y. Goshen, I. Yaniv, and E. Karnieli PAX3/Forkhead Homolog in Rhabdomyosarcoma Oncoprotein Activates Glucose Transporter 4 Gene Expression in Vivo and in Vitro J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5312 - 5324. [Abstract] [Full Text] [PDF]

				G. Maor and E. Karnieli The Insulin-Sensitive Glucose Transporter (GLUT4) Is Involved in Early Bone Growth in Control and Diabetic Mice, But Is Regulated through the Insulin-Like Growth Factor I Receptor Endocrinology, April 1, 1999; 140(4): 1841 - 1851. [Abstract] [Full Text]

				W. Garvey, T. Huecksteadt, and M. Birnbaum Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus Science, July 7, 1989; 245(4913): 60 - 63. [Abstract] [PDF]